Skip to main content

SUPPRELIN

NDC 67979-002 · Endo USA, Inc.

Generic namehistrelin acetate
Dosage formIMPLANT
RouteSUBCUTANEOUS
Active ingredient(s)HISTRELIN ACETATE
Strength50 mg/1
Pharmacologic classGonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]
Marketing categoryNDA

Packages

67979-002-01 — 1 VIAL, GLASS in 1 CARTON (67979-002-01) / 1 IMPLANT in 1 VIAL, GLASS

Billed under HCPCS

J9226 — Histrelin implant (supprelin la), 50 mg Medicare Part B payment limit (ASP + 6%): $37491.97

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.